Eosinophil-selective mediators in human strongyloidiasis

Parasite Immunology

Volumn 28, Issue 8, 2006, Pages 397-400

  Mir, A ^a,b   Benahmed, D ^a   Igual, R ^b   Borras R ^a   O'Connor, J E ^a   Moreno, M J ^b   Rull, S ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL FRANCESC DE BORJA   (Spain)

Author keywords

Eosinophil; Eotaxin; IL 5; Strongyloidiasis

Indexed keywords

EOTAXIN; INTERLEUKIN 5;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; HUMAN; IMMUNITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIBODIES, HELMINTH; CHEMOKINES, CC; CHEMOTAXIS, LEUKOCYTE; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-5; MALE; MIDDLE AGED; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

STRONGYLOIDES STERCORALIS;

EID: 33746217098     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2006.00826.x     Document Type: Article

References (33)

1. Grove DI. Human Strongyloidiasis. Adv Parasitol 1996; 38: 251-309.
2. Keiser PB & Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 2004; 17: 208-217.
3. Cremades Romero MJ, Pellicer Ciscar C, Menendez Villanueva R et al. Strongyloides stercoralis infection in patients with bronchial obstructive pathology. Arch Bronconeumol 1997; 33: 384-388.
4. Roman-Sanchez P, Pastor-Guzman A, Moreno-Guillen S, Igual-Adell R, Suner-Generoso S & Tornero-Estebanez C. High prevalence of Strongyloides stercoralis among farm workers on the Mediterranean coast of Spain: analysis of the predictive factors of infection in developed countries. Am J Trop Med Hyg 2003; 69: 336-340.
5. Urban JF Jr, Madden KB, Svetic A et al. The importance of Th2 cytokines in protective immunity to nematodes. Immunol Rev 1992; 127: 205-220.
6. Rothenberg ME. Eosinophilia. N Engl J Med 1998; 338: 1592-1600.
7. Klion AD & Nutman TB. The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol 2004; 113: 30-37.
8. Jose PJ, Griffiths-Johnson DA, Collins PD et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994; 179: 881-887.
9. Lamkhioued B, Renzi PM, Abi-Younes S et al. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 1997; 159: 4593-4601.
10. Lilly GM, Woodruff PG, Camargo CA et al. Elevated plasma eotaxin in patients with acute asthma. J Allergy Clin Immunol 1999; 104: 786-790.
11. Jundt F, Anagnostopoulos I, Bommert K et al. Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils. Blood 1999; 94: 2065-2071.
12. Mir A, Minguez M, Tatay J et al. Elevated serum eotaxin levels in patients with inflammatory bowel disease. Am J Gastroenterol 2002; 97: 1452-1457.
13. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P & Luster AD. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 1996; 2: 449-456.
14. Evans CA, Garcia HH, Hartnell A et al. Elevated concentrations of eotaxin and interleukin-5 in human neurocysticercosis. Infect Immun 1998; 66: 4522-4525.
15. Matthews AN, Friend DS, Zimmermann N et al. Eotaxin is required for the baseline level of tissue eosinophils. Proc Natl Acad Sci USA 1998; 95: 6273-6278.
16. Arakaki T, Iwanaga M, Kinjo F, Saito A, Asato R & Ikeshiro T. Efficacy of agar-plate culture in detection of Strongyloides stercoralis infection. J Parasitol 1990; 76: 425-428.
17. Hernandez-Pomi A, Borras-Salvador R & Mir-Gisbert A. Analysis of cytokine and specific antibody profiles in hydatid patients with primary infection and relapse of disease. Parasite Immunol 1997; 19: 553-561.
18. Campos A, Romar A, Basomba A, Pelaez A & Villalmanzo IG. Evaluation of total serum IgE levels. I. Study of a healthy adult population. Allergol Immunopathol 1981; 9: 495-500.
19. Herbert DR, Lee JJ, Lee NA, Nolan TJ, Schad GA & Abraham D. 1996. Role of IL-5 in innate and adaptive immunity to larval Strongyloides stercoralis in mice. J Immunol 2000; 165: 4544-4551.
20. Rotman HL, Yutanawiboonchai W, Brigandi RA et al. Strongyloides stercoralis: eosinophil-dependent immune-mediated killing of third stage larvae in BALB/cByJ mice. Exp Parasitol 1996; 82: 267-278.
21. Ovington KS, McKie K, Matthaei KI, Young IG & Behm CA. Regulation of primary Strongyloides ratti infections in mice: a role for interleukin-5. Immunology 1998; 95: 488-493.
22. Clutterbuck EJ, Hirst EM & Sanderson CJ. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. Blood 1989; 73: 1504-1512.
23. Abraham D, Rotman HL, Haberstroh HF et al. Strongyloides stercoralis: protective immunity to third-stage larvae in BALB/cByJ mice. Exp Parasitol 1995; 80: 297-307.
24. Brigandi RA, Rotman HL, Yutanawiboonchai W et al. Strongyloides stercoralis: role of antibody and complement in immunity to the third stage of larvae in BALB/cByJ mice. Exp Parasitol 1996; 82: 279-289.
25. Yazdanbakhsh M, Tai PC, Spry CJ, Gleich GJ & Roos D. Synergism between eosinophil cationic protein and oxygen metabolites in killing of schistosomula of Schistosoma mansoni. J Immunol 1987; 138: 3443-3447.
26. MacKenzie JR, Mattes J, Dent LA & Foster PS. Eosinophils promote allergic disease of the lung by regulating CD4(+) Th2 lymphocyte function. J Immunol 2001; 167: 3146-3155.
27. Nakamura H, Weiss ST, Israel E, Luster AD, Drazen JM & Lilly CM. Eotaxin and impaired lung function in asthma. Am J Respir Crit Care Med 1999; 160: 1952-1956.
28. Badaro R, Carvalho EM, Santos RB, Gam AA & Genta RM. Parasite-specific humoral responses in different clinical forms of strongyloidiasis. Trans R Soc Trop Med Hyg 1987; 81: 149-150.
29. Atkins NS, Conway DJ, Lindo JF, Bailey JW & Bundy DA. L3 antigen-specific antibody isotype responses in human strongyloidiasis: correlations with larval output. Parasite Immunol 1999; 21: 517-526.
30. Porto AF, Neva FA, Bittencourt H et al. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol 2001; 23: 503-507.
31. Neva FA, Filho JO, Gam AA et al. Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis. J Infect Dis 1998; 178: 1856-1859.
32. Carvalho EM & Da Fonseca Porto A. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Parasite Immunol 2004; 26: 487-497.
33. Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Canonica GW, Jasmin C & Azzarone B. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J Clin Invest 1998; 101: 2129-2139.